212 related articles for article (PubMed ID: 29934308)
1. Structural insights into the heterodimeric complex of the nuclear receptors FXR and RXR.
Zheng W; Lu Y; Tian S; Ma F; Wei Y; Xu S; Li Y
J Biol Chem; 2018 Aug; 293(32):12535-12541. PubMed ID: 29934308
[TBL] [Abstract][Full Text] [Related]
2. Ligand binding and heterodimerization with retinoid X receptor α (RXRα) induce farnesoid X receptor (FXR) conformational changes affecting coactivator binding.
Wang N; Zou Q; Xu J; Zhang J; Liu J
J Biol Chem; 2018 Nov; 293(47):18180-18191. PubMed ID: 30275017
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the interaction between retinoic acid receptor/retinoid X receptor (RAR/RXR) heterodimers and transcriptional coactivators through structural and fluorescence anisotropy studies.
Pogenberg V; Guichou JF; Vivat-Hannah V; Kammerer S; Pérez E; Germain P; de Lera AR; Gronemeyer H; Royer CA; Bourguet W
J Biol Chem; 2005 Jan; 280(2):1625-33. PubMed ID: 15528208
[TBL] [Abstract][Full Text] [Related]
4. Retinoid X receptor (RXR) agonist-induced antagonism of farnesoid X receptor (FXR) activity due to absence of coactivator recruitment and decreased DNA binding.
Kassam A; Miao B; Young PR; Mukherjee R
J Biol Chem; 2003 Mar; 278(12):10028-32. PubMed ID: 12519787
[TBL] [Abstract][Full Text] [Related]
5. Identification of DRIP205 as a coactivator for the Farnesoid X receptor.
Pineda Torra I; Freedman LP; Garabedian MJ
J Biol Chem; 2004 Aug; 279(35):36184-91. PubMed ID: 15187081
[TBL] [Abstract][Full Text] [Related]
6. Structural basis for negative cooperativity within agonist-bound TR:RXR heterodimers.
Putcha BD; Wright E; Brunzelle JS; Fernandez EJ
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6084-7. PubMed ID: 22474364
[TBL] [Abstract][Full Text] [Related]
7. Defining the communication between agonist and coactivator binding in the retinoid X receptor α ligand binding domain.
Boerma LJ; Xia G; Qui C; Cox BD; Chalmers MJ; Smith CD; Lobo-Ruppert S; Griffin PR; Muccio DD; Renfrow MB
J Biol Chem; 2014 Jan; 289(2):814-26. PubMed ID: 24187139
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the functional role of steroid receptor coactivator-1 in ligand-induced transactivation by thyroid hormone receptor.
Jeyakumar M; Tanen MR; Bagchi MK
Mol Endocrinol; 1997 Jun; 11(6):755-67. PubMed ID: 9171239
[TBL] [Abstract][Full Text] [Related]
9. Structural basis of the farnesoid X receptor/retinoid X receptor heterodimer on inverted repeat DNA.
Jiang L; Liu X; Liang X; Dai S; Wei H; Guo M; Chen Z; Xiao D; Chen Y
Comput Struct Biotechnol J; 2023; 21():3149-3157. PubMed ID: 37287811
[TBL] [Abstract][Full Text] [Related]
10. Heterodimerization of Retinoid X Receptor with Xenobiotic Receptor partners occurs in the cytoplasmic compartment: Mechanistic insights of events in living cells.
Dash AK; Yende AS; Jaiswal B; Tyagi RK
Exp Cell Res; 2017 Nov; 360(2):337-346. PubMed ID: 28939253
[TBL] [Abstract][Full Text] [Related]
11. Bile salt excretory pump: biology and pathobiology.
Suchy FJ; Ananthanarayanan M
J Pediatr Gastroenterol Nutr; 2006 Jul; 43 Suppl 1():S10-6. PubMed ID: 16819395
[TBL] [Abstract][Full Text] [Related]
12. Structural Insights into the Interaction of the Intrinsically Disordered Co-activator TIF2 with Retinoic Acid Receptor Heterodimer (RXR/RAR).
Senicourt L; le Maire A; Allemand F; Carvalho JE; Guee L; Germain P; Schubert M; Bernadó P; Bourguet W; Sibille N
J Mol Biol; 2021 Apr; 433(9):166899. PubMed ID: 33647291
[TBL] [Abstract][Full Text] [Related]
13. A mutation mimicking ligand-induced conformational change yields a constitutive RXR that senses allosteric effects in heterodimers.
Vivat V; Zechel C; Wurtz JM; Bourguet W; Kagechika H; Umemiya H; Shudo K; Moras D; Gronemeyer H; Chambon P
EMBO J; 1997 Sep; 16(18):5697-709. PubMed ID: 9312028
[TBL] [Abstract][Full Text] [Related]
14. Modulation of RXR function through ligand design.
Pérez E; Bourguet W; Gronemeyer H; de Lera AR
Biochim Biophys Acta; 2012 Jan; 1821(1):57-69. PubMed ID: 21515403
[TBL] [Abstract][Full Text] [Related]
15. The effect of regulating molecules on the structure of the PPAR-RXR complex.
Amber-Vitos O; Chaturvedi N; Nachliel E; Gutman M; Tsfadia Y
Biochim Biophys Acta; 2016 Nov; 1861(11):1852-1863. PubMed ID: 27616290
[TBL] [Abstract][Full Text] [Related]
16. Discovery of a "Gatekeeper" Antagonist that Blocks Entry Pathway to Retinoid X Receptors (RXRs) without Allosteric Ligand Inhibition in Permissive RXR Heterodimers.
Watanabe M; Fujihara M; Motoyama T; Kawasaki M; Yamada S; Takamura Y; Ito S; Makishima M; Nakano S; Kakuta H
J Med Chem; 2021 Jan; 64(1):430-439. PubMed ID: 33356247
[TBL] [Abstract][Full Text] [Related]
17. Effects of ligand binding on the association properties and conformation in solution of retinoic acid receptors RXR and RAR.
Egea PF; Rochel N; Birck C; Vachette P; Timmins PA; Moras D
J Mol Biol; 2001 Mar; 307(2):557-76. PubMed ID: 11254382
[TBL] [Abstract][Full Text] [Related]
18. Structure basis of bigelovin as a selective RXR agonist with a distinct binding mode.
Zhang H; Li L; Chen L; Hu L; Jiang H; Shen X
J Mol Biol; 2011 Mar; 407(1):13-20. PubMed ID: 21262235
[TBL] [Abstract][Full Text] [Related]
19. The vitamin D hormone and its nuclear receptor: molecular actions and disease states.
Haussler MR; Haussler CA; Jurutka PW; Thompson PD; Hsieh JC; Remus LS; Selznick SH; Whitfield GK
J Endocrinol; 1997 Sep; 154 Suppl():S57-73. PubMed ID: 9379138
[TBL] [Abstract][Full Text] [Related]
20. The methyl transferase PRMT1 functions as co-activator of farnesoid X receptor (FXR)/9-cis retinoid X receptor and regulates transcription of FXR responsive genes.
Rizzo G; Renga B; Antonelli E; Passeri D; Pellicciari R; Fiorucci S
Mol Pharmacol; 2005 Aug; 68(2):551-8. PubMed ID: 15911693
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
